Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ANI Pharmaceuticals Inc shares valued at $426,407 were sold by Rowland Thomas Andrew on Aug 12 ’25. At $85.71 per share, Rowland Thomas Andrew sold 4,975 shares. The insider’s holdings dropped to 40,794 shares worth approximately $3.67 million following the completion of this transaction.
Also, Lalwani Nikhil sold 56,960 shares, netting a total of over 4,894,573 in proceeds. Following the sale of shares at $85.93 each, the insider now holds 411,219 shares.
Before that, Gutwerg Ori had sold 5,873 shares from its account. In a trade valued at $508,191, the SVP, GENERICS traded ANI Pharmaceuticals Inc shares for $86.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,873 shares, worth approximately $7.56 million.
As published in their initiating research note from H.C. Wainwright on July 10, 2025, ANI Pharmaceuticals Inc [ANIP] has been a Buy and the price target has been revised to $84. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of March 12, 2025, JP Morgan has initiated its “an Overweight” rating for ANIP. Earlier on December 11, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for ANIP stock.
Analyzing ANIP Stock Performance
On last trading session, ANI Pharmaceuticals Inc [NASDAQ: ANIP] rose 1.42% to $90.0. The stock’s lowest price that day was $88.3, but it reached a high of $90.23 in the same session. During the last five days, there has been a surge of approximately 30.42%. Over the course of the year, ANI Pharmaceuticals Inc shares have jumped approximately 50.80%. Shares of the company reached a 52-week high of $90.23 on 08/14/25 and a 52-week low of $52.74 on 01/13/25.
Support And Resistance Levels for ANI Pharmaceuticals Inc (ANIP)
According to the 24-hour chart, there is a support level at 88.79, which, if violated, would cause prices to drop to 87.58. In the upper region, resistance lies at 90.72. The next price resistance is at 91.44. RSI (Relative Strength Index) is 86.30 on the 14-day chart, showing overbought technical sentiment.
Is ANI Pharmaceuticals Inc subject to short interest?
Stocks of ANI Pharmaceuticals Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.2 million shares to 2.21 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 2.0 million shares. A jump of 9.26% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.17 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.17.
Which companies own the most shares of ANI Pharmaceuticals Inc (ANIP)?
In terms of ANI Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 90 in the next 12 months, up nearly 1.42% from the previous closing price of $88.74. Analysts anticipate ANI Pharmaceuticals Inc stock to reach 94 by 2025, with the lowest price target being 86. In spite of this, 2 analysts ranked ANI Pharmaceuticals Inc stock as Buy at the end of 2025. On October 11, 2024, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $68.
